DEPARTMENT OF CORRECTIONS
Executive Summary
DEPARTMENT OF CORRECTIONS: Glaxo's Volmax is a twice-daily oral formulation of albuterol. An article in March 20 "The Pink Sheet" (T&G-6) incorrectly said the drug, which has an NDA pending at FDA, was a once-daily formulation.